Dissent: an alternative interpretation of MAST-I. Multicentre Acute Stroke Trial--Italy Group

Affiliations

G Tognoni et al. Lancet. 1995.

. 1995 Dec 9;346(8989):1515.

doi: 10.1016/s0140-6736(95)92050-1.

¹ Department of Cardiovascular Research, Mario Negri Institute for Pharmacological Research, Milano, Italy.

No abstract available

Comment in

MAST-I: agreeing to disagree. Multicentre Acute Stroke Trial--Italy Group.
Horton R. Horton R. Lancet. 1995 Dec 9;346(8989):1504. doi: 10.1016/s0140-6736(95)92043-9. Lancet. 1995. PMID: 7491039 No abstract available.
Thrombolytic therapy for acute ischaemic stroke: promising, perilous, or unproven?
Sandercock P. Sandercock P. Lancet. 1995 Dec 9;346(8989):1504-5. doi: 10.1016/s0140-6736(95)92044-7. Lancet. 1995. PMID: 7491040 No abstract available.
Multicentre Acute Stroke Trial--Italy.
Carolei A, Marini C, Motolese M. Carolei A, et al. Lancet. 1996 Feb 10;347(8998):392; author reply 393. Lancet. 1996. PMID: 8598713 Clinical Trial. No abstract available.